Avidin-biotin binding interaction (null)

The **avidin-biotin binding interaction** refers to the exceptionally strong non-covalent association between the protein avidin and the small molecule biotin. **Avidin** is a tetrameric glycoprotein found primarily in egg whites of birds, reptiles, and amphibians. Each subunit can bind one molecule of biotin with extremely high affinity (\(K_d \approx 10^{-15}\) M), making it one of the strongest known non-covalent biological interactions[1][2][3][5]. This bond is highly stable under extreme conditions such as variations in pH, temperature, organic solvents, and denaturing agents. The avidin-biotin system has been widely adopted for laboratory applications including enzyme-linked immunosorbent assay (**ELISA**), immunohistochemistry (**IHC**), Western blotting, affinity purification, cell surface labeling, fluorescence-based detection methods like FACS, electrophoretic mobility shift assays (**EMSA**), and more[1][2]. In these applications, either proteins or antibodies are conjugated with biotin ("biotinylation"), which then allows them to be captured or detected using avidin or its analogs immobilized on various supports. Variants such as **streptavidin** and **NeutrAvidin**, which have similar structures but reduced nonspecific binding due to lack of glycosylation or neutral charge properties respectively, are often preferred for certain experimental contexts due to lower background signal[4][5]. This system is not considered a therapeutic target—rather it serves as an essential molecular tool for biotechnology research. There are no drugs that act on this "target," nor does it play any direct role in human disease outside its use as an experimental reagent. There may be some confusion when listing "Avidin/biotin binding interaction" among drug targets because it describes an engineered molecular pair rather than a natural receptor/enzyme/transporter involved in pathophysiology or therapy. Thus, > The entry "Avidin/biotin binding interaction" should not be classified as a canonical druggable target; instead it represents one of biotechnology's most important affinity systems for detection and purification purposes.[1][2]

Other names

Avidin–biotin interactionBiotin–avidin bindingStreptavidin–biotin interaction (when referring to the broader family)

Not applicable, as this is not a therapeutic target. The mechanism involves extremely high-affinity non-covalent binding between avidin and biotin.